Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

Recent News and Articles on the Keywords: 576 + 0.49 + investigate  Related to the article below (Last Update: 8/5/2008)

RC2 Reports Second Quarter Results; Reaffirms 2008 Full Year ... MarketWatch - Jul 30, 2008 ... income $ (0.25) $ 0.49 ============== ======== Weighted average shares outstanding: Basic 17586 21170 Diluted 17586 21565 Selected Consolidated Balance ...RCRC Banner Corporation Announces Second Quarter Results; Includes ... MarketWatch - Jul 28, 2008 ... Advertising and marketing 1677 1418 1867 3095 3724 State/municipal business and use taxes 576 564 470 1140 878 Amortization of core deposit intangibles ...BANR - KIDS Prosperity Bancshares, Inc.(R) Reports Second Quarter Earnings Earthtimes (press release), UK - Jul 23, 2008 ... and other earning assets 175 682 1,3371,576 Total interest income 81979 87300 166444 167163 Interest expense - deposits 25210 31421 54155 60534 Interest ...PRSP - KIDS A股对H股溢价率为36.38% 扬子晚报, China - Jul 29, 2008 5日恒生AH股溢价指数收报136.38点，下跌0.49点或0.36%，显示当前A股股价平均比H股股价溢价36.38%。其中，海螺水泥、中国铁建、中国平安、交通银行继续呈现负溢价。 ...SHA:601328 - SHA:600585 - SHA:601318 台指期若守穩月線有機會往上挑戰高點 聯合新聞網, Taiwan - Jul 23, 2008 (週三外資成交金額為576億，三大法人合計成交金額為744億。) 期貨市場方面，週三四大期指受亞股激勵均以跳高開出，盤中多頭氣勢強勁，整場均呈現看回不回的緩步上漲 ...

Scientists from the CIMA from the University of Navarra investigate a molecule for diagnosing hypertensive cardiopathy

Scientists from the Center for Applied Medical Research (CIMA) from the University of Navarra investigate whether cardiotrophin 1, a molecule that can be measured in blood, can be used as a diagnostic marker for hypertensive cardiopathy. After studying the relationship of this molecule with this disease, the experts believe that cardiotrophin 1 is useful for preventing or controlling the damaging effects on the heart suffered by patients with this disease. In Spain, there are four million patients with this illness, a number that supposes fifty percent of the eight million patients with high blood pressure.

The research on this cardiovascular illness was shared today during the course of the International Congress Frontiers in Transnational Research of Cardiovascular Diseases, held in the CIMA, and in which dozens of Spanish, Germans, British and Dutch scientists participated.

Currently, these types of illnesses are the number one cause of doctor’s visits, hospitalization and death worldwide. As it is foreseen that their frequency will increase in the next decades, experts propose the soonest possible application of the latest biomedical and biotechnological advances for the diagnosis, prevention and treatment of these pathologies.

Article continues below and (thank you)

Stroke and Atrial Fibrillation Prevention

Cardiotrophin 1 as it intervenes in the earliest phases of hypertensive cardiopathy, if we act on it we can prevent complications such as cardiac insufficiency, atrial fibrillation, strokes and even patient death.

The speakers also touched on aspects of high blood pressure, which affects more than 25% of the adult population. For example, they revised the advances in the diagnosis and treatment of lesions that this pathology produces in the heart, the brain and the kidneys, saying that is one of the primary causes of problems such as cardiac insufficiency, vascular dementia and kidney failure.

In addition, they studied the harmful impact of diabetes and obesity on the heart and the arteries. In this sense, they presented pharmaceutical advances that can lead to a revolution in the current therapy used. Finally, they spoke of atherosclerosis (arterial hardening), the most common illness and with the worst consequences. They also analyzed the use of biomarkers for early detection of future strokes (whether cerebral or heart attacks) and cellular therapy in order to minimize its consequences.